Member Info for EGTP

concur with that timmo :-)

From previous Oilex RNS - The operation is expected to start in July, with an initial target gas rate of 2 million standard cubic feet per day –

Value per cubic feet is ?

DYOR

My friend my comments refer to your ‘but over the past 12 months my whole family has’ Comment string

Hindsight is wonderful, so If your intent was for readers here to take this on board and make trust and future investment decisions accordingly - all I’m suggesting is they might subscribe to premium then they can see your posts made prior to Jan 11th pause and make up their own minds as to your recorded belief in AffiDX just over 3 months ago

As I say in my most recent experience the current innova and surescreen tests most definitely didn’t act as an early warning system and PCR didn’t either - so it could be the case that no current tests are fit for purpose as early warning systems - but just my opinion

Glad your still invested - best wishes

Chemo ‘without’ side effects - I meant to say

Beautiful sunny day again :-)

Yes ?the JGE306 points about AffiDX obviously a mute point now, just as they were in January when first mentioned to me after the pause. But anyone with premium can look back through posts and draw their own conclusions about his current statement.

But in fairness yes there was clearly a problem with AffiDX after omnicron appeared, but up to Omnicron I very much doubt it was due to the ability to mass produce and sell because M19 had finally bagged HUA in the EU and begun marketing with suspected capacity to produce up to 25 million tests weekly (let alone the ABDX capability)

The key point here is to appreciate exactly what AffiDX was specifically developed to be at the start of the pandemic - this being an coronavirus early warning system to detect potential infectiousness / Asymptomatic (CT levels up to 27 100% accurate) before symptoms developed, and not for users that already had covid with CT levels well over 30.

And with this in mind I can confirm I’ve just come though a short but heavy hit of covid (my first) I felt something in the post Thursday week developed some symptoms by Friday and finally tested myself last Saturday after symptoms became heavier (no AffiDX left) but my wife’s NHS supply of Innova and Surescreen confirmed I had covid, yet didn’t pick up any covid in her despite the fact she also had mild symptoms.

Because of this - the NHS told her to go take an immediate PCR, amazingly results again were negative, so she duly went off to work on the Monday, she finally tested positive last Wednesday and is now recovering from her 3rd hit of covid

So to summarise I figured I’d come into personal close contact with at least 25 people since I picked covid up (4 now have it) and my wife’s done 2 shifts in an NHS rehabilitation ward (admittedly wearing heavy PPE) before finally testing positive.

Once again impossible for me to comment on previous AffiDX performance for its exact intent and purpose because I never developed symptoms.

But it should be noted that the exact science of CT values and detection is still not definitive, and if the current Innova and Surescreen tests are intended to be the exact same early warning system AffiDX was, they clearly don’t work, and in this particular case PCR totally failed also.

So there’s most definitely an urgent need for an accurate early warning system to detect coronavirus as there is indeed a massive future trillion dollar market to detect many other conditions including Sepsis Cortisol Vitamin D Cancer heart disease ect

It would be fantastic if Avacta played a part in this, but at the moment they seem pretty focused on AVA6000 revolutionising the world by delivering Chemo with side effects !

DYOR

Mr Adventurous - thank-you I do appreciate your surgical analysis of my commentary

I think the saying in life goes something like this -

The people that know ‘how’ will always work for the people that know ‘why’

I’ve little idea how - but from losing two loved ones from some of these deadly killers exampled I certainly know ‘why’

And my point is this - if avacta precision is conclusively proven to safely deliver targeted Doxorubicin bullets (chemo) into humans without side effects, then it is likely able to be adapted to precision target deliver many other severe illness treatments normally associated with side effects

Success with AVA6000 will be truly sensational but I personally believe the bigger picture is way beyond this

It’s a beautiful sunny day, get yourselves outside and enjoy it ! :-)

Has to be imminent ?

I’m also LT Avacta holder and reading into this morning’s update, I’m pretty sure although AffiDX is completely dismissed in terms of the SP in both stocks, it’s very much alive and an announcement could pop up out of the blue at anytime

The lows here are obscene - just like avacta anyone one selling out here now (unless traders) completely clueless and risking a fortune as this stock could easily quadruple within 24 hours with the right news

DYOY

October 2021 update suggests either or with Affimers been the primary

https://www.modernwater.com/2021/10/06/monitoring-wastewater-to-provide-faster-real-time-detection-of-covid-19-and-other-pathogens/

This is significant pretty sure the Microtox PD, wastewater detector is coated with Affimers - and they are now picking up orders round the world

https://www.lse.co.uk/rns/DVRG/deepverge-q1-production-orders-up-39-to-1635m-y5jreh3py9cdkwe.html

No Myles hasn’t sold any, and why the hell would any half intelligent holder sell now at these lows when avacta are on the verge of re-writing science for the better

DYOR

I have multiple websites that are updated daily, so for me and the way i operate the Medusa 19 page is now just a holding page until further information - what this will be is everyone’s guess

In the meantime the stocks going down like most others because theres a war on with a very uncertain direction, so little appetite to do anything but cash up for a rainy day, and not enough buyers today to counter it

Bella is right AffiDX could just have been a soft launch, as the product albeit the most accurate LFT in the world was still as complicated with too many parts as many others - the future of LFTS needs to be simple 1 piece with results in minutes maybe even seconds for them to be user friendly and household essentials - Avacta eluded as far back as December update that another future test was getting developed or at least the intention - so I’m still open to that idea as accurate simple self testing for all kinds will be a future trillion dollar market

But in the meantime AVA6000 precision LG Chen and Affimer sales is what I’m looking forward too

GLA / DYOR

So far as I was led to believe from within - medusa19 were manufacturing the RSPT and AffiDX as far back as last July / August and directly supplying their own business contacts in the EU and the likes Greatbear.co.uk

Exact quantity of production and how they were exactly doing this I don’t know as not invited in to see with my own eyes, and this information originated from me (not Ophidian) we both questioned how they could have mastered the TT so much quicker than ABDX (hence not publicly sharing our thoughts) which led to the possible conclusion Mologic were manufacturing some of the tricky components and Medusa simply finishing off the more straight forward bits and packaging up

So my belief is still that additional incomes were earned beyond what we are aware, and also the Medusa 19 is indeed a total bag of surprises

All irrelevant now as so far as we are aware AffiDX rebranded as Meduflow is currently caped - though intriguing development to M19 site tonight

DYOR

If TW is the paymaster - how on earth does his back bedroom https://www.*************.com manage to fulltime sponsor 1 possibly several operators to fulltime bash Avacta and other stocks ?

https://uk.globaldatabase.com/company/*************-ltd its last accounts are a joke, they’re not even small company

Has to be a front for a bigger operator, or operators – Let me think Hmmmm

Have good weekend all genuine holders

DYOR

No problems wishey - my life journey just the same as anyone else will be in the end - just a little older wiser and battle hardened

Yes I think AS is an amazing scientist who explains his work it so simple terms to laymen like me - but as a CEO and businessman leader - hmmmm

If Affimers and precision turn out to be as good as hoped - it will be easier to sell than water in the desert so his short comings will be irrelevant

DYOR

Life can be brutal Jezza - but the journey of life is still rich and unforgettable, IMO we should all be learning and living every day as if it’s the last !

Same age as me if You 53 this year ?

Best Wishes EGTP

I don’t doubt there’s a few casualties out there, good honest holders that lost grip in the uncontrollable storm.

Its difficult to keep belief when it seems everyone around has lost it. But the wise or brave buy when everyone else is selling

So for anyone this matters to, I’m still holding and have gratefully added at this ludicrously oversold price

I personally feel AffiDX will be back, for a number of very prominent reasons (and some not so) but that’s for the rest of you to decide

I feel what most just don’t get about AVA6K is anything beyond a basic understanding that its ‘just another cancer trial’ currently doing well dosing 3 brave terminally ill patients - now at 1.5 times normal doseage with virtually zero side effects, this in itself is fantastic news for the patients and for Avacta

But the point being missed here, is the fact this is not just another cancer treatment that will take years and £billions to get approval and commercialise.

I don’t understand the exact science / facts figures so happy to be corrected, but in short, its a novel bolt on precision targeted delivery system (like precision bombing) made possible by the use of ‘Affimers’ ( Avacta copyright) https://en.wikipedia.org/wiki/Affimer

If this precision delivery system is very shortly proven to be ‘conclusively’ successful (all indications looking very good) it should be applicable to just about every other targeted serious illness cure currently on the market, pretty fast with little further development

Example sepsis is a major killer, and just like chemo, the current ****tail of treatments often kill the patient in the process. I can vouch for this first hand, having to stood by my fiancées hand less than 5 years back watching her die of sepsis aged 49, having come into the hospital perfectly healthy

I also lost my mum aged 49 after a long horrendous 8 year fight with Leukaemia reducing her from 12 stone to 6.5 stone in her final year

So I feel I understand very deeply the power and life changing possibilities Avacta Affimer and Precision can deliver to the world

As always just my opinion !

DYOR

Morning folks - almost impossible to buy that dip even small quantities, but got there in the end with a good chunk, and I’d say this would be the last best opportunity for major shorts to close.

I’ve now seen the Paul Hill Interview 5 times and I don’t doubt others many more times.

IMO there’s absolutely no hint, indications, music in his voice, or body language that suggests AffiDX won’t be coming back on the market.

As with all other recent RNS and VOX interviews AS has simply learned to under promise, drop the hype, and not commit to any timelines or predictions anymore, he’s not ramping AV6000 either, and we all know he could provide the market much more SP lifting facts about it, but chooses not citing patient confidentiality.

The AffiDX prototype has already been built and worked, all they are doing is modifying a few parts, this isn’t a major project they are embarking with ABDX - and keep in mind they too stand to hugely benefit from AffiDX opportunity, so there’s no logical reason their research redeployment services will even be charged to Avacta in this joint venture

AS as well as Us, ABDX and M19 all know there will be significant opportunities now and well into the future to earn from Coronavirus as well as Cortisol Sepsis, Vitamin D etc, so I very much doubt this chance will be relinquished.

So for me as long as the current information on site https://www.medusa19.com/en/ remain unchanged AffiDX is coming back to market soon

GLA and DYOR

I feel I should repeat part of my post from last week - for the benefit of any newcomers or poorly informed

I’m very aware many now suspect a new improved AffiDX for SARS Cov won’t be back on the shelf - and yes you could be right.

But consider this - there is a very capable company out there Abingdon Health ‘ABDX’ who have heavily invested and geared up to sell AffiDX and are currently working around the clock with Avacta scientists to provide the perfected antibody for the New AffiDX test.

I understand this process might take up to 6 weeks from whenever it was started, which I personally suspect was before the 10th January update.

There is also another extremely capable company, run by one of the most powerful retailers in the Uk that has also invested a significant amount of time and money some £22 plus million (much more than Avacta) to gear up to specifically sell AffiDX SARS Cov under the brand ‘Meduflow’

This company by coincidence has a significant interest in the success of Avacta, and they have also worked incredibly hard to achieve the almost impossible ‘Home use Authorisation’ HUA to sell AffiDX directly into homes in the EU.

My M19 source confirms they have already achieved significant ‘Meduflow’ pre sales, the source is also absolutely adamant in belief they will be selling AffiDX in substantial quantities anytime soon, and anyone who cares to check https://www.medusa19.com/en/ will also see these expectations and position hasn't changed

So you might ignore / discount the additional substantial short term to mid income opportunity to Avacta at your peril

DYOR

Evening folks hope we’re all a bit happier now, I’m confident looking back in 6 to 12 months time, this date will be noted as Destiny day for Avacta.

Ok so despite all the doomongers nay sayers, and out and fraudulent derampers our tech works in therapeutics, and not only does it work - it most definitely works better and safer than the current worldwide standard of chemotherapy delivery !

So how much could this new precision delivery method be worth to the world folks ?

I must also comment on AffiDX because I’m very aware many now suspect a new improved AffiDX for SARS Cov won’t be back on the shelf - and yes you could be right.

But consider this - there is a very capable company out there Abingdon Health ‘ABDX’ who have heavily invested and geared up to sell AffiDX and are currently working around the clock with Avacta scientists to provide the perfected antibody for the New AffiDX test.

I understand this process might take up to 6 weeks from whenever it was started, which I personally suspect was before the 10th January update.

There is also another extremely capable company, run by one of the most powerful retailers in the Uk that has also invested a significant amount of time and money some £22 plus million (much more than Avacta) to gear up to specifically sell AffiDX SARS Cov under the brand ‘Meduflow’

This company by coincidence has a significant interest in the success of Avacta, and they have also worked incredibly hard to achieve the almost impossible ‘Home use Authorisation’ HUA to sell AffiDX directly into homes in the EU.

My M19 source confirms they have already achieved significant ‘Meduflow’ pre sales, the source is also absolutely adamant in belief they will be selling AffiDX in substantial quantities anytime soon, and anyone who cares to check https://www.medusa19.com/en/ will also see these expectations and position hasn't changed

So you might ignore / discount the additional substantial short term to mid income opportunity to Avacta at your peril

DYOR

If anyone cares to look back at the April 2021 placing notes they will see -

As a further component of the Placing, 111,111,111 Warrants are also being issued at an exercise price of 0.9 pence per share for a period of 2 years (one Warrant for every two new Ordinary Shares). In the event the Warrants are exercised in due course in full, associated proceeds will be £1.0 million, with the result that the Company will have raised gross proceeds of £2.0 million at a weighted average price of 0.60 pence per share.

There’s also an identical clause for the August 2021 placing warrants this time 1p

DYOR and thinking